Experimental autoimmune encephalomyelitis (EAE) is a CD4 + T cell-mediated disease of the central nervous system. Serum amyloid P component (SAP) is a highly conserved plasma protein named for its universal presence in amyloid deposits. Here we report that SAP-transgenic mice had unexpectedly attenuated EAE due to impaired encephalitogenic responses. Following induction with myelin oligodendroglial glycoprotein (MOG) peptide 35-55 in complete Freund's adjuvant, SAPtransgenic mice showed reduced spinal cord inflammation with lower severity of EAE attacks as compared with control C57BL/6 mice. However, in SAP-Knockout mice, the severity of EAE is enhanced. Adoptive transfer of Ag-restimulated T cells from wild type to SAP-transgenic mice, or transfer of SAP-transgenic Ag-restimulated T cells to control mice, induced milder EAE. T cells from MOG-primed SAP-transgenic mice showed weak proliferative responses. Furthermore, in SAP-transgenic mice, there is little infiltration of CD45-positive cells in the spinal cord. In vitro, SAP suppressed the secretion of interleukin-2 stimulated by P-selectin and blocked P-selectin binding to T cells. Moreover, SAP could change the affinity between a4-integrin and T cells. These data suggested that SAP could antagonize the development of the acute phase of inflammation accompanying EAE by modulating the function of P-selectin. Keywords: experimental autoimmune encephalomyelitis (EAE); serum amyloid P component (SAP); P-Selectin Serum amyloid P component (SAP) is a member of the pentraxin family of proteins secreted by hepatocytes in response to inflammatory challenges. It has been widely used as a clinical indicator for inflammation. [1] [2] [3] [4] [5] It is a highly conserved plasma protein named for its universal presence in amyloid deposits and a normal component of a number of basement membranes, including the glomerular basement membrane. 6 It is the single normal circulating protein with specific calciumdependent binding to DNA and chromatin in physiological conditions. 7 When bound to ligand, SAP forms a stable decamer with two pentameric rings. 8 Interaction of SAP with nuclear ligands, including chromatin and small nuclear ribonucleoprotein (snRNP), is important in the handling of chromatin exposed by cell death and has a role in the clearance of nuclear ligands from apoptotic and necrotic cells. 9-11 SAP binds in vivo both to apoptotic cells, the surface blebs of which bear chromatin fragments, and to nuclear debris released by necrosis. 11 The human disease multiple sclerosis 12 and its animal model, experimental autoimmune encephalomyelitis (EAE), are mediated by inflammatory cells recruited from the circulation into the central nervous system (CNS). Disease is initiated when activated autoreactive T cells cross the blood brain barrier into the healthy CNS. When Ag is encountered, these cells initiate inflammation and the recruitment of inflammatory effector cells to the CNS, resulting in devastating demyelination and axon destruction. EAE can be induced either by immunizing animals with myelin components (actively induced EAE) or by transferring encephalitogenic T cells (adoptive transfer EAE). 13, 14 Different strains of small animals are differentially susceptible to EAE. 15 C57BL/6 mice develop a monophasic disease upon myelin oligodendroglial glycoprotein (MOG) 35-55 challenge, with extensive demyelination and inflammation in the CNS, and MOG35-55-induced EAE is frequently used in experiments using gene-targeted mice. 16 It is generally accepted that a4-integrins have a predominant role in T-cell trafficking across the blood-brain barrier (BBB) during EAE, as they mediate both T-cell rolling and firm adhesion of T cells to the BBB. 17 In contrast, the adhesion molecules generally mediating leukocyte rolling along the vascular wall, such as E-and L-selectin, are not required for the development of EAE in C57BL/6 and SJL mice. [18] [19] [20] Similarly, P-selectin has been shown to have no role in the recruitment of inflammatory cells across the BBB during EAE; 18 nevertheless, its role in EAE pathogenesis remains controversial. 21, 22 The current study was designed to address the role of SAP in the pathogenesis of EAE, using both SAP-transgenic mice and SAPdeficient mice. Our data showed that SAP deletion increased behavioral and pathological changes of EAE, and overexpression of SAP decreased behavioral and pathological changes of EAE in mice. Furthermore, our studies demonstrated that the function of SAP suppressing EAE is related to modulating the function of P-selectin.
Serum amyloid P component (SAP) is a member of the pentraxin family of proteins secreted by hepatocytes in response to inflammatory challenges. It has been widely used as a clinical indicator for inflammation. [1] [2] [3] [4] [5] It is a highly conserved plasma protein named for its universal presence in amyloid deposits and a normal component of a number of basement membranes, including the glomerular basement membrane. 6 It is the single normal circulating protein with specific calciumdependent binding to DNA and chromatin in physiological conditions. 7 When bound to ligand, SAP forms a stable decamer with two pentameric rings. 8 Interaction of SAP with nuclear ligands, including chromatin and small nuclear ribonucleoprotein (snRNP), is important in the handling of chromatin exposed by cell death and has a role in the clearance of nuclear ligands from apoptotic and necrotic cells. [9] [10] [11] SAP binds in vivo both to apoptotic cells, the surface blebs of which bear chromatin fragments, and to nuclear debris released by necrosis. 11 The human disease multiple sclerosis 12 and its animal model, experimental autoimmune encephalomyelitis (EAE), are mediated by inflammatory cells recruited from the circulation into the central nervous system (CNS). Disease is initiated when activated autoreactive T cells cross the blood brain barrier into the healthy CNS. When Ag is encountered, these cells initiate inflammation and the recruitment of inflammatory effector cells to the CNS, resulting in devastating demyelination and axon destruction. EAE can be induced either by immunizing animals with myelin components (actively induced EAE) or by transferring encephalitogenic T cells (adoptive transfer EAE). 13, 14 Different strains of small animals are differentially susceptible to EAE. 15 C57BL/6 mice develop a monophasic disease upon myelin oligodendroglial glycoprotein (MOG) 35-55 challenge, with extensive demyelination and inflammation in the CNS, and MOG35-55-induced EAE is frequently used in experiments using gene-targeted mice. 16 It is generally accepted that a4-integrins have a predominant role in T-cell trafficking across the blood-brain barrier (BBB) during EAE, as they mediate both T-cell rolling and firm adhesion of T cells to the BBB. 17 In contrast, the adhesion molecules generally mediating leukocyte rolling along the vascular wall, such as E-and L-selectin, are not required for the development of EAE in C57BL/6 and SJL mice. [18] [19] [20] Similarly, P-selectin has been shown to have no role in the recruitment of inflammatory cells across the BBB during EAE; 18 nevertheless, its role in EAE pathogenesis remains controversial. 21, 22 The current study was designed to address the role of SAP in the pathogenesis of EAE, using both SAP-transgenic mice and SAPdeficient mice. Our data showed that SAP deletion increased behavioral and pathological changes of EAE, and overexpression of SAP decreased behavioral and pathological changes of EAE in mice. Furthermore, our studies demonstrated that the function of SAP suppressing EAE is related to modulating the function of P-selectin.
RESULTS

SAP-transgenic mice develop milder EAE
To study the effects of SAP on EAE-related immunopathology, we compared the susceptibility of control and SAP-transgenic mice with EAE induction with subcutaneous injection of 200 mg peptide, consisting of amino acids 35-55 of MOG 35-55 in complete Freund's adjuvant and pertussis toxin; control mice developed a monophasic disease characterized by ascending paralysis 10-18 d after immunization and SAP-transgenic mice showed resistance to the development of EAE. Table 1 summarizes the neurobehavioral features of MOG35-55-induced EAE in control and SAP-transgenic mice. In the initial experiment, when 200 mg MOG35-55 was injected, 15 out of 15 (100%) wild-type mice developed fatal EAE, whereas only 12 out of 15 (80%) SAP-transgenic mice developed EAE. EAE induced with 200 mg of MOG35-55 showed more severe weakness and paralysis in wild-type mice than in SAP-transgenic mice, with higher peak scores and imperfect recovery, with more residual neurological impairment (Table 1 and Figure 1 ). Wild-type mice had higher EAE scores and greater weight change in day 30 postimmunization (p.i.) than did SAP-transgenic animals ( Figure 1 ), indicating more extensive tissue injury. These results indicated that increase of SAP suppresses the severity of EAE in mice.
SAP-deficient mice develop exaggerated EAE
To further determine how SAP deficiency influences EAE, we immunized wild-type mice and SAP-deficient mice with 100 mg MOG35-55 and monitored them daily. Although most of mice in both groups developed EAE, neurologic dysfunction in SAP-Knockout mice was markedly more severe. Table 2 shows clinical scores over a 30-day period from the above mice. A total of 13 out of 15 (87%) SAPdeficient mice developed EAE, whereas only 11 out of 15 (73%) wildtype mice developed EAE. In the SAP-deficient mice, the mean clinical score was 2.29 (±0.83) versus 1.25 (±0.76) in wild-type mice and the mean weight decrease was greater (data not shown). SAP-deficient mice had higher EAE scores in day 30 p.i., compared with wild-type mice (Supplementary Figure 1) .
Adoptive transfer of EAE resistance
To determine whether SAP overexpression on Ag-specific T cells was beneficial to EAE, we transferred EAE using MOG-sensitized T cells from SAP-transgenic mice. We induced EAE by adoptively transferring MOG-sensitized T cells from control mice and SAP-transgenic mice to wild-type mice. The result was little development of disease in recipient mice injected by encephalitogenic cells from SAP-transgenic mice. As expected, transfer of Ag-specific T cells from control mice to wild-type mice as an internal control resulted in clinical signs of EAE (Figures 2a and b) . So, the result indicated cells from MOG-immunized SAP-transgenic mice induced EAE poorly in C57BL/6 animals, as compared with those from wild-type mice. We also induced EAE by adoptively transferring MOG-sensitized T cells from wild-type mice to control mice and SAP-transgenic mice. We observed an attenuated development of disease in SAP-transgenic recipient mice, whereas control mice readily developed EAE (Figures 2c and d) . The result indicated that SAP-transgenic mice were resistant to the MOGsensitized T cells from wild-type mice. So, these experiments showed that the severity of EAE is closely related to cellular immunity of T cells; however, the enriched environment of SAP also could inhibit the severity by suppressing the cellular immunity of T cells.
Cellular infiltration in SAP-transgenic mice with EAE
We next performed histopathological analysis on spinal cords of wild type and SAP-transgenic mice with active EAE to determine the extent and nature of the cellular infiltrate between the two groups of mice. Representative spinal cord sections from wild-type mice obtained at peak days after disease induction had extensive cellular infiltration in the meninges and white matter (Figures 3a, c, e and g ). Sections obtained from SAP-transgenic mice had little cellular infiltration and inflammation throughout the spinal cord, compared with wild-type 
mice (Figures 3b, d, f and h). The result indicated that SAP inhibited the inflammation of CNS induced by EAE.
SAP-transgenic T cells have reduced proliferative capacity compared with wild-type T cells SAP-transgenic mice, which showed poorly EAE severity than did wild-type mice, suggested the possibility of altered-T cell effector function. To test the possibility that attenuated active and transferred EAE in SAP-transgenic mice could be due to a poor proliferative capacity of SAP-transgenic T cells, we performed in vitro antigen-recall proliferation assays with lymphocytes isolated from draining peripheral lymph node and spleen. In C57BL/6 wild-type mice, a prominent dose-dependent T cell proliferation response to MOG35-55 was detected after immunization in the draining peripheral lymph node and a lesser degree in the spleen ( Figure 4 ). In contrast, in SAPtransgenic mice, the MOG35-55-specific T cell proliferation was limited and maintained at an obviously low level to wild-type mice in the onset, peak and end of the EAE ( Figure 4 ).
SAP-transgenic cells have an altered cytokine profile compared with wild-type T cells
T-helper type 1 (Th1) cells have an essential role for the development and progression of EAE through the production of Th1 cytokines such as interferon-g and tumor necrosis factor-a; Th17 cells also have an Figure 2) showed that there was a remarkable increase of the interferon-g and interleukin (IL)-17 proportion in wild-type mice than SAPtransgenic mice, which means that the Th1 and Th17 reaction were inhibited during the peak of EAE in SAP-transgenic mice.
SAP suppress the activation of P-selectin to T cells In Kubes' study, 21, 22 it has been proved that there are important overlapping roles for both P-selectin and a4-integrin in mediating leukocyte-endothelial cell interactions in the EAE. So, we wonder if SAP resists the severity of EAE by modulating the function of P-selectin or a4-integrin. To figure out this, we performed the following assays with T lymphocytes isolated from draining peripheral lymph node. In the first assay, we measured the secretion of IL-2, using enzyme-linked immunosorbent assay assay. The result showed that in the presence of anti-mouse CD3, T lymphocytes secreted more IL-2 under the stimulation of 20 mg P-selectin. However, when 10 mg murine SAP (mSAP) was added, the secretion of IL-2 decrease obviously (Figure 5a ). The result implies that mSAP can suppress the function of P-selectin to stimulate T lymphocytes. And then, the binding assay was performed. The result showed that mP-Rg can bind to T cells in vitro. However, when SAP was added, the binding of mP-Rg to mouse T cells was clearly inhibited (Figures 5b and c ). Our data demonstrate the capacity of SAP to inhibit the binding and stimulation of P-selectin to T lymphocytes.
SAP can change the conformational states of a4-integrin Because flow cytometers have the ability to discriminate between free and bound fluorescent ligand in a homogeneous assay, we constructed a novel fluorescent peptide derived from the high affinity Leu-Asp-Val sequence to measure binding affinities in real time of a4-integrin on leukocytic cells. 23 In these experiments, we preincubated cells with the peptide for 10 min, then IgG, SAP or Mn 2+ was added as stimulator. Flow cytometric analysis was performed continuously for up to 500 s to measure the peptide binding affinity. Figure 6 shows an analysis of the binding characteristics of fluorescent Leu-Asp-Val following addition. We found that SAP as a stimulator can obviously change the binding affinity of Leu-Asp-Val than its IgG control does, Mn 2+ as a positive control. That means SAP can change the conformational states of the a4-integrin to affect its function.
DISCUSSION
In this study, we examined the role of SAP in the pathogenesis of EAE, using both SAP-transgenic mice and SAP-deficient mice. Our data showed increased severity of EAE in SAP-deficient mice and decreased severity of EAE in SAP-transgenic mice. And meanwhile, adoptive transfer of Ag-restimulated T cells from wild type to SAP-transgenic mice, or transfer of SAP-transgenic Ag-restimulated T cells to control mice, induced weaker symptoms of EAE. Moreover, lymph node and spleen cells from MOG-primed SAP-transgenic mice showed weak proliferative responses and TH-1 and TH-17 responses; furthermore, the result of immunohistochemistry showed that there is little infiltration of the spinal cord by CD45 and hematoxylin and eosin in SAP-transgenic mice which suffered from EAE. All the results indicate that SAP can effectively suppress the development of EAE. SAP belongs to the pentraxin family of proteins, which are endowed with Ca 2+ -dependent lectin-like binding activity. Native human SAP is arranged as a flat cyclic pentamer consisting of five noncovalently associated identical subunits of 25 462 kDa each. 24, 25 Among the SAP suppresses the development of EAE Z Ji et al pentraxins, SAP and C-reactive protein are secreted proteins with a similar molecular mass, a high degree of conservation throughout evolution and a comparable genomic organization. Both SAP and Creactive protein are produced and catabolized in the liver of humans and rodents, 25, 26 but they show considerable species differences in their regulation. C-reactive protein is highly inducible in humans, but not in mice during inflammation. In contrast, SAP is the major acutephase protein in mice. 27 Multiple sclerosis is considered a classical T cell-mediated autoimmune disease with a complex genetic background. The mechanisms involved in producing the acute lesion of multiple sclerosis seem to share similarities with those described for EAE. Over the past decade, progress has been made in elucidating the immunological events, in particular. Despite such progress, however, many important critical issues remain unknown.
In EAE model, subcutaneous injection of myelin antigen into animals or adoptive transfer of purified MOG-specific T cells obtained from EAE mice into naive mice can both induce the disease. Our results of active EAE showed that the increase of SAP suppressed the severity of EAE (Figure 1 and Supplementary Figure 1) , and the adoptive transfer experiments (Figures 2a and b) showed that the milder disease was directly related to SAP-transgenic mice donor cells and disease severity was mediated by decreased cellular immunity. Additionally, the proliferative capacity of SAP-transgenic T cells was suppressed in the onset, peak and end of EAE (Figure 4 ). All these results suggest that the suppressed T-cellular activity of SAP-transgenic mice induced the decreased severity of the EAE. Moreover, we also observed an attenuated development of disease in SAP-transgenic recipient mice injected by encephalitogenic cells from wild-type mice (Figures 2c and d) . This suggests that the enriched environment of SAP also can suppress the cellular immunity of T-encephalitogenic cells in SAP-transgenic mice conversely. These results indicated that SAP suppressed the development of EAE by regulating the activity of T-cellular activity.
IL-2, a 15 kDa a-helical cytokine, is produced almost exclusively by activated T cells and promotes proliferation of lymphocytes. 28, 29 It is important for the differentiation of CD4 + T cells into Th1 and Th2 effector subsets. [30] [31] [32] P-selectin (CD62P) is a member of the selectin 
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Z Ji et al family of cell adhesion molecules, which interacts with P-selectin glycoprotein ligand-1 (CD162) for leukocyte rolling on stimulated endothelial cells and heterotypic aggregation of activated platelets onto leukocytes. 33 Some study have proved that P-selectin can mediate the recruitment of Th1 into inflamed tissues; 34 here, we first report that P-selectin is able to stimulate the secretion of IL-2, which is neutralized by SAP (Figure 5a ). The result suggests that P-selectin can affect the development of EAE by modulating the recruitment of Th1, and SAP can bind to P-selectin to suppress this effect.
Researchers have demonstrated that T-cell recruitment across the BBB during EAE is unique because of the predominant involvement of a4-integrins. After the seminal study by Yednock et al. 35 demonstrating that antibodies (Abs) blocking a4-integrin inhibit EAE by blocking T-cell interaction with the BBB, numerous following studies confirmed and extended the predominant involvement of a4-integrin/ vascular cell adhesion protein-1 in inflammatory cell recruitment into the CNS in different EAE models in a number of species. [36] [37] [38] [39] However, the role of P-selectin in CNS autoimmunity has been controversial. Some studies have reported that anti-P-selectin Abs 40 had not any impact on the incidence, severity or development of EAE. Despite this, a number of studies making direct observations in vivo have demonstrated a central role for P-selectin in mediating leukocyte rolling in the CNS vasculature in a number of inflammatory models, [41] [42] [43] [44] including EAE. 45 Our own observations are in complete agreement with these previous studies. Indeed, according to some researcher's hypothesis, only by combining the blockade of P-selectin with blockade of a4-integrin could recruitment be sufficiently reduced to impact disease and reveal the role of P-selectin in disease development. This is evidenced by dual treatment translated into a significant inhibition of disease development, as demonstrated by not only a delay in the onset of clinical signs of disease, but also the significant recovery following the initial attack. Our data showed that SAP can not only suppress the function of P-selectin to stimulate the secretion of IL-2 and bind to T cells, but also change the affinity between a4-integrin and T cells. So, we have proved that SAP suppresses the development of EAE by modulating the function of a4-integrin and Pselectin. We also noticed that SAP has the ability to activate microglia; 46 however, the result of our research showed that this ability has not induced obvious inflammation in the CNS (Figure 3) . It indicates that SAP may be considered as a potential disease-modifying agent in EAE. In summary, these discoveries provide a basis for further investigation of SAP in the treatment and prevention of EAE and multiple sclerosis.
METHODS
Peptides and antibodies
Rat MOG35-55 peptides were obtained from Biosynth International (Naperville, IL, USA) and purified by high performance liquid chromatography, and the purity of the peptide was 495%. The sequence of MOG35-55 was MEVGWYRSPFSRVVHLYRNGK. The mSAP was isolated from mouse ascites to homogeneity, according to a previously published protocol. 47 Purified Hamster Anti-Mouse CD3e, Rat Anti-Mouse IL-17A, Rat Anti-Mouse CD62P and fluorescein isothiocyanate-conjugated Rat Anti-Mouse CD4 were purchased from BD Pharmingen (Basel, Switzerland); Rat anti-mouse CD45 was purchased from AbD Serotec (Kidlington, UK). Rat anti-Mouse IFN-g was purchased from Invitrogen (Camarillo, CA, USA).
Mice
C57BL/6J mice were obtained from Shanghai SLAC Laboratory Animal Co. Ltd (Shanghai, China). SAP-transgenic mice were constructed by our lab. SAPdeficient mice on a C57BL/6 background were kindly provided by Dr Mark B. Pepys (Royal Free and University College Medical School, London, UK).
The genotype of mice was confirmed by PCR before and after the experiments. The procedure for animal surgery was performed in accordance with the Guidelines of Animal Care and Use Committee of the Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences.
SAP-transgenic mice were constructed according to the method described below. The wild type, full-length mSAP cDNA was cloned by reverse transcriptase-PCR from mRNAs isolated from mouse livers and its sequence was confirmed by DNA sequencing. For construction of mSAP transgene the forward primer, 5¢-GTCTGCGGATCCATGGACAAGCTACTGCTT-3¢ and the reverse primer, 5¢-ACAGTACTCGAGATCCCAGACACGGGGCCT-3¢ were used to amplify the insert from mSAP cDNA. After restriction enzyme digestion with BamHI/XhoI, it was ligated into pCMV-Tag5A (Invitrogen). For high expression in vivo, it was cut with BciVI to generate a 2659 bp fragment, before injection into the pronuclei of mouse 129 embryonic stem cells. Transgenic offsprings (five male and seven female in total) were verified and subsequently screened by PCR, employing the following primers: 5¢-TACAGTGACCTTTCCCGCTCTCAGAGTCT-3¢ and 5¢-ACGACTCACTAT AGGGCGAATTGGGTACAC-3¢, or 5¢-CGTGGATAGCGGTTTG ACTCACG GGGATT-3¢ and 5¢-GAGAGCGGGAAAGGTCACTGTAGGTTCGGAAA-3¢. Positive progenies were further confirmed by Southern blotting of the isolated DNAs with the 32 P-labeled fragment of mSAP plasmid. Two transgenic lines with homogeneous mSAP expression were established, among which founder A was expanded for further investigation and is referred to hereafter as SAP transgenic mice. The animals used in these experiments had been backcrossed to C57BL/6J (C57) mice for 12 generations.
Induction and analysis of EAE
Active immunization. Induction of EAE was performed as previously described. 48 Briefly, mice were subcutaneously injected at two sites with 100 or 200 mg of rat MOG peptide 35-55 (MEVGWYRSPFSRVVHLYRNGK; 495% purity; Bio-Synthesis, Naperville, IL, USA), emulsified in complete Freund's adjuvant containing 400 mg of Mycobacterium tuberculosis (Difco Laboratories, Detroit, MI, USA). On the same day (day 0) and on day 2 p.i., mice were intravenously injected with 200 ng of pertussis toxin (Sigma-Aldrich, St Louis, MO, USA). All mice were weighed, examined and graded daily for neurological signs in a blinded manner as follows: 0, no disease; 1, decreased tail tone or slightly clumsy gait; 2, tail atony and moderately clumsy gait and/or poor righting ability; 3, limb weakness; 4, limb paralysis; and 5, moribund state. Average disease scores were assessed daily. Additionally, in the EAE model, we documented the weight changes during the disease course, as we have found this to be a valuable additional measure for disease activity. And only mice with a score of at least 2 for 42 consecutive days were judged to have fully developed EAE. The maximum clinical score achieved by each animal during the 30-day-observation period was used to calculate average maximum clinical scores for each experimental group. To study the time course of disease development, average clinical scores were calculated daily for each group of mice and plotted. The day of EAE onset was calculated by adding the first day of clinical signs for individual mice and dividing by the number of mice in the group. The day of peak EAE was calculated by determining the first day of maximum EAE score for individual mice and dividing by the number of mice in the group. Mean maximum score was calculated by adding peak scores of individual mice and dividing by the number of mice. Cumulative EAE score was calculated by adding total EAE scores from onset until day 30 p.i. for individual mice and dividing by the number of mice. Active immunization with MOG35-55 induced monophasic EAE in B6 mice and was followed for 30 days. Animals were euthanized if scores were worse than grade 4.
Adoptive transfer. To prepare encephalitogenic cells for adoptive transfer of EAE, mice were immunized with MOG/complete Freund's adjuvant in the same fashion as for active EAE. Spleens and lymph nodes were collected 8 days p.i., single cell suspensions were prepared and RBCs were lysed. Cells (6Â10 6 cells ml À1 ) were cultured in RPMI 1640 medium (supplemented with 10% fetal bovine serum, 2mML-glutamine, 1 mM sodium pyruvate, 100 IU ml À1 penicillin/streptomycin and 2Â10 À5 M 2-ME (Invitrogen Life Technologies, Carlsbad, CA, USA)), with MOG35-55 (20 mg ml À1 ) and IL-12 (30 ng ml À1 ) (R&D Systems, Minneapolis, MN, USA). After 3 days of initiation SAP suppresses the development of EAE Z Ji et al of culture, the cells were harvested, washed in phosphate-buffered saline (PBS) and injected into recipient mice that were irradiated sublethally (500 rad) within 16 h before cell injection. All mice were weighed, examined and graded daily after cell transfer. 49 
Immunohistochemistry
For immunohistochemical analysis of CNS tissues at different stages of EAE, mice were killed by intracardiac perfusion with ice-cold PBS, followed by 4% paraformaldehyde solution, under anesthesia. Spinal cords were rapidly dissected; 6 mm cryostat sections were prepared, rinsed in PBS, incubated with 0.3% hydrogen peroxide, blocked by incubation with 10% bovine serum albumin at 37 1C for 1 h, then incubated overnight at 4 1C with primary Abs at the dilution indicated (rat anti-mouse CD45 mAbs, 1/1000 (clone MCA 1388; Serotec)); on day 2, tissues were incubated with appropriate biotinylated secondary Abs (goat anti-rat) at 37 1C for 1 h, then with diaminobenzidine. Sections were washed thrice with PBS after each incubation step (except for bovine serum albumin). All Abs were diluted in 1% bovine serum albumin in PBS. Tissues were rinsed in double distilled H 2 O, dehydrated and mounted. Negative controls were incubated with preimmune IgG.
T-cell purification and in vitro T-cell proliferation CD4 + T cells were isolated from pooled spleens of mice, using Mouse T Cell CD4 Subset Column Kit, as per the manufacturer's protocol (R&D Systems). Briefly, spleen leukocyte suspensions are incubated with a mixture of monoclonal antibodies and then loaded onto T-cell subset columns. The resulting column eluate contains a highly enriched T-cell subset population. For T-cell proliferation, draining lymph node cells from MOG35-55-immunized mice were incubated in a 96-well plate (1Â10 5 per well) in the presence of MOG35-55 or Con A (Sigma-Aldrich) at the indicated concentration or in medium alone (background). For all experiments, culture medium was RPMI 1640, supplemented with 10% fetal bovine serum (Invitrogen Life Technologies), 2 mM L-glutamine, 1 mM sodium pyruvate, 100 IU ml À1 penicillin/streptomycin and 2Â10 À5 M 2-ME (Invitrogen Life Technologies). After 72 h in culture, remove the culture plate from the incubator and add 50 ml of cell lysis reagent to each well and wait for 10 min. Add 100 ml of AMR PLUS (Lonza Rockland, Rockland, ME, USA) to each appropriate well and incubate the plate for 2 min at room temperature. Then, the culture plate was analyzed with luminometer (Bio-Tek, Atlanta, GA, USA).
Flow cytometry
Single-cell suspensions (1Â10 6 cells ml À1 ) from lymph nodes obtained were washed and resuspended in PBS buffer. Cells were stained for surface markers with primary Abs and appropriate fluorescein isothiocyanate-conjugated secondary Abs in fluorescence-activated cell sorting (FACS) buffer at 4 1C for 40 min. Cells were washed twice and resuspended in the 200-400 ml of PBS for flow cytometry analysis, as described before. 50, 51 Analysis was performed with a FACSCalibur (BD Biosciences, San Diego, CA, USA) equipped with CellQuest software (BD Biosciences) and 10 000 events were acquired. Data were analyzed with FlowJo software (Tree Star, San Carlos, CA, USA).
For the binding experiments, CD4 + cells were preincubated with mouse IgG or P-selectin Rg and Ca 2+ , respectively, and with mouse SAP, anti-CD62P or EDTA for 60 min. Then samples were incubated with fluorescein isothiocyanate-conjugated Abs to mouse IgG and analyzed with FACSCalibur (BD Biosciences).
Enzyme-linked immunosorbent assay
For analysis of IL-2, CD4 + cells were preincubated with different stimulator (hamster IgG, anti-mouse CD3e, mouse IgG, P-selectin Rg, 10 mg mouse SAP and 20 mg anti-CD62P). Supernatants from triplicate cultures were harvested after 24 h. IL-2 was quantified by using mouse IL-2 enzyme-linked immunosorbent assay kit (BioSource International Inc., Camarillo, CA, USA).
Kinetic analysis of peptide binding by FACS analysis
The affinity states of VLA-4 can be recognized by mAbs sensitive to its molecular conformation. Recently, it has also been shown that the conformations of VLA-4 can be evaluated with a peptide ligand derived from the LeuAsp-Val sequence of the VLA-4-binding region of fibrinogen. Peptide-binding affinity has been measured by flow cytometric analysis. Single-cell suspensions from lymph nodes obtained were washed and resuspended in PBS buffer (1-2Â10 6 cells ml À1 ). Then cells were preincubated with the 3 mM fluorescent VLA-4-specific peptide for 10 min at 37 1C and 500 rpm stirring. Flow cytometric analysis was performed; the samples were analyzed for 10-20 s to establish a base line, then the stimulus (IgG, SAP or Mn 2+ ) was added and FACS acquisition was immediately re-established, losing 5-10 s of the total time course. Flow cytometric analysis was performed continuously for up to 500 s. The resulting data were analyzed using FlowJo software (Tree Star). 23 
Statistical analysis
Statistical analysis was assessed by one-way ANOVA, followed by StudentNewman-Keuls analyses. An unpaired t-test was used for the analysis of quantitative data of cell counting in the brain. Data were presented as means±s.d. Difference in which Po0.05 was considered statistically significant.
